Altamira Therapeutics Ltd.
Altamira Therapeutics Ltd. (CYTO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CYTO · as of Jun 9, 2026
Key Statistics
Explore Altamira Therapeutics Ltd. Data
cyto stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
cyto competitorsCYTO
BLCM
CWBR
HTGMQ
IMPL
INFIQStock Performance
Full HistoryAbout Altamira Therapeutics Ltd.
Altamira Therapeutics Ltd. is a biotechnology firm dedicated to pioneering new treatments for critical medical needs that are currently underserved. Its marketed offerings include Bentrio, a non-pharm…
what is altamira therapeutics ltd. · cyto stock overview · altamira therapeutics ltd. company profile · who is altamira therapeutics ltd. ceo · cyto NASDAQ · altamira therapeutics ltd. headquarters · altamira therapeutics ltd. business segments
About Stock Overview & Key Data
Altamira Therapeutics Ltd. (CYTO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 6, 2014. As of the latest trading session, CYTO stock price is $0.30, with a market capitalization of $1.1M. The stock has returned +216.79% over the past 12 months and +0.00% year-to-date.
In fiscal year 2023, Altamira Therapeutics Ltd. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Altamira Therapeutics Ltd. (CYTO) stock price is $0.30. The stock is traded on NASDAQ under the ticker symbol CYTO. The 52-week range is $0.30 – $0.42.